TLR7 and neoplasm: GC vaccines, which were synthesized by covalent attachment of TLR7 agonist with MG7-Ag tetra-epitope, combined with 5- fluorouracil chemotherapy decreased tumor sizes and increased long-term survival rates by improving T cell responses and decreasing myeloid-derived suppressor cells (MDSCs) (164).